Galbraith R M, Galbraith G M
Immunology. 1981 Dec;44(4):703-10.
Mitogen-activated normal human peripheral blood lymphocytes bind transferrin to specific membrane receptors. In this study, lymphocytes stimulated with phytohaemagglutinin for 0-66 hr were examined to determine the relation of this phenomenon to cellular activation and related metabolic events. Transferrin receptors were first detected at 20-24 hr. This event was consistently preceded by RNA and protein turnover which commenced during the first 6 hr of culture, whereas initiation of DNA synthesis was detected concurrently with the appearance of receptors or slightly later (24-30 hr). Exposure of cells to inhibitors of RNA and protein synthesis early during culture (at 0 or 24 hr) prevented the expression of transferrin receptors, but also caused generalized metabolic failure, and abrogated cellular activation. In contrast, later addition of these agents at 48 hr did not interfere significantly with the process of activation, but did suppress the terminal increase in receptor-bearing cells observed during the final 18 hr in control cultures lacking inhibitor. After deliberate thermal stripping of receptors from activated cells, the reappearance of membrance binding sites which normally occurred within 30 min, was also blocked by cycloheximide, puromycin and actinomycin D. However, similar inhibition of DNA which was induced by hydroxyurea had much less effect upon both the initial appearance of receptors and their reappearance after ligand-induced depletion. These results demonstrate that the appearance of transferrin receptors upon human lymphocytes is dependent upon cellular activation and requires synthesis of protein and RNA.
有丝分裂原激活的正常人外周血淋巴细胞可将转铁蛋白结合到特定的膜受体上。在本研究中,检测了用植物血凝素刺激0至66小时的淋巴细胞,以确定这种现象与细胞活化及相关代谢事件的关系。转铁蛋白受体在20至24小时首次被检测到。在这一事件之前,RNA和蛋白质周转持续进行,这在培养的最初6小时开始,而DNA合成的起始与受体的出现同时被检测到或稍晚(24至30小时)。在培养早期(0或24小时)将细胞暴露于RNA和蛋白质合成抑制剂中,可阻止转铁蛋白受体的表达,但也会导致普遍的代谢衰竭,并消除细胞活化。相比之下,在48小时后添加这些试剂不会显著干扰活化过程,但会抑制在缺乏抑制剂的对照培养物中最后18小时观察到的受体阳性细胞的终末增加。在用热方法从活化细胞中去除受体后,通常在30分钟内出现的膜结合位点的重新出现也被环己酰亚胺、嘌呤霉素和放线菌素D所阻断。然而,羟基脲诱导的类似DNA抑制对受体的最初出现及其在配体诱导耗竭后的重新出现影响要小得多。这些结果表明,人淋巴细胞上转铁蛋白受体的出现依赖于细胞活化,并且需要蛋白质和RNA的合成。